Improved freedom from PSA failure with whole pelvic irradiation for high-risk prostate cancer

International Journal of Radiation Oncology Biology Physics

Volumn 42, Issue 5, 1998, Pages 1055-1062

  Seaward, Samantha A ^a   Weinberg, Vivian ^a   Lewis, Pamalar ^a   Leigh, Bryan ^b   Phillips, Theodore L ^a   Roach III, MacK ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Gleason score; High risk; Prostate cancer; Prostate specific antigen; Radiation therapy

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; HUMAN; MAJOR CLINICAL STUDY; MALE; PELVIS; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; RADIATION DOSE; TREATMENT OUTCOME;

ANALYSIS OF VARIANCE; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; HUMANS; LYMPHATIC METASTASIS; MALE; PROSPECTIVE STUDIES; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; TREATMENT FAILURE;

EID: 0032440910     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(98)00282-X     Document Type: Article

References (38)

1. Bagshaw M.A., Cox R.S., Ray G.R. Status of radiation treatment of prostate cancer at Stanford University. NCI Monogr. 7:1988;47-60.
2. McGowan D.G. The value of external field radiation therapy in carcinoma of the prostate. Int J Radiat Oncol Biol Phys. 7:1981;1333-1339.
3. Perez C.A., Michalski J., Brown K.C., Lockett M.A. Nonrandomized evaluation of pelvic lymph node irradiation in localized carcinoma of the prostate. Int J Radiat Oncol Biol Phys. 36:1996;573-584.
4. Ploysongsang S., Aron B.S., Shehata W.M., Jazy F.K., Scott R.M., Ho P.Y., Morand T.M. Comparison of whole pelvis versus small-field radiation therapy for carcinoma of prostate. Urology. 27:1986;10-16.
5. Rangala N., Cox J.D., Byhardt R.W., Wilson J.F., Greenburg M., da Conceicas A.L. Local control and survival after external irradiation for adenocarcinoma of the prostate. Int J Radiat Oncol Biol Phys. 8:1982;1909-1914.
6. Aristizabal S.A., Steinbronn D., Heusinkveld R.S. External beam radiotherapy in cancer of the prostate. The University of Arizona experience. Radiother Oncol. 1:1984;309-315.
7. Asbell S.O., Caplan R.J., Perez C.A., Rubin P., Doggett R.L., Sause W.T., Rotman M., Emami B., Shin K., Pilepich M.V. Impact of surgical staging on evaluating the radiotherapeutic outcome in RTOG 77-06, a Phase III study for T1b-T2b N0 M0 prostatic carcinoma. (Abstr.) Int J Radiat Oncol Biol Phys. 32:1995;143.
8. Asbell S.O., Krall J.M., Pilepich M.V., Baerwald H., Sause W.T., Hanks G.E., Perez C.A. Elective pelvic irradiation in stage A2, B carcinoma of the prostate Analysis of RTOG 77-06 . Int J Radiat Oncol Biol Phys. 15:1988;1307-1316.
9. Bagshaw M.A. Perspectives on radiation treatment of prostate cancer history and current focus . Murphy G.P. Prostatic carcinoma. 1979;151-173 PSG Publishing Co, Littletown, MA.
10. Harisiadis L., Veenema R.J., Senyszyn J.J., Puchner P.J., Tretter P., Romas N.A., Chang C.H., Lattimer J.K., Tannenbaum M. Carcinoma of the prostate treatment with external radiotherapy . Cancer. 41:1978;2131-2142.
11. Hill D.R., Crews Q.E., Walsh P.C. Prostate carcinoma radiation treatment of the primary and lymphatics . Cancer. 34:1974;156-160.
12. Neglia W.J., Hussey D.H., Johnson D.E. Megavoltage radiation therapy for carcinoma of the prostate. Int J Radiat Oncol Biol Phys. 2:1977;873-882.
13. Perez C.A., Pilepich M.V., Zivnuska F. Tumor control in definitive irradiation of localized carcinoma of the prostate. Int J Radiat Oncol Biol Phys. 12:1986;523-531.
14. Pistenma D.A., Bagshaw M.A., Freiha F.S. Extended field radiation therapy for prostatic adenocarcinoma status report of a limited prospective trial . Johnson D.E., Samuels M.L. Cancer of the genitourinary tract. 1979;229-247 Raven Press, New York.
15. Rasp G.M., Pisansky T.M., Haddock M.G., Cha S.S., Earle J.D. Elective pelvic nodal irradiation in patients with clinically localized prostate cancer at high risk for pelvic nodal involvement. (Abstr.) Int J Radiat Oncol Biol Phys. 36S:1996;245.
16. Rosen E., Cassady J.R., Connolly J., Chaffey J.T. Radiotherapy for prostate carcinoma the JCRT experience (1968-1978). II. Factors related to tumor control and complications . Int J Radiat Oncol Biol Phys. 11:1985;723-730.
17. Rounsaville M.C., Green J.P., Vaeth J.M., Purdon R.P., Heltzel M.M. Prostatic carcinoma limited field irradiation . Int J Radiat Oncol Biol Phys. 13:1987;1013-1020.
18. Whitmore W.F. Jr, Batata M., Hilaris B. Prostatic irradiation Iodine-125 implantation . Johnson D.E., Samuels M.L. Cancer of the genitourinary tract. 1979;195-205 Raven Press, New York.
19. Zagars G.K., von Eschenbach A.C., Johnson D.E., Oswald M.J. The role of radiation therapy in stages A2 and B adenocarcinoma of the prostate. Int J Radiat Oncol Biol Phys. 14:1988;701-709.
20. Zagars G.K., von Eschenbach A.C., Johnson D.E., Oswald M.J. Stage C adenocarcinoma of the prostate an analysis of 551 patients treated with external beam irradiation . Cancer. 60:1987;1489-1499.
21. Perez C.A., Lee H.K., Georgiou A., Lockett M.A. Technical factors affecting morbidity in definitive irradiation for localized carcinoma of the prostate. Int J Radiat Oncol Biol Phys. 28:1994;811-819.
22. Roach M. III, Rosenthal S., Hunter D., Ryu J., Pickett B., Chan A., et al. One hundred consecutive patients treated for clinically localized prostate cancer by 6-field conformal radiation therapy Acute toxicity and lessons learned from the UCSF/Davis experience . (Abstr.) Radiology. 189:1993;183.
23. Partin A.W., Kattan M.W., Subong E.N., Walsh P.C., Wojno K.J., Oesterling J.E., Scardino P.T., Pearson J.D. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multiinstitutional update. JAMA. 277:1997;1445-1451.
24. Roach M. III, Marquez C., Yuo H.-S., Narayan P., Coleman L., Nseyo U.O., Navvab Z., Carroll P.R. Predicting the risk of lymph node involvement using the pre-treatment PSA and Gleason score in men with clinically localized prostate cancer. Int J Radiat Oncol Biol Phys. 28:1994;33-37.
25. Roach M. III. You say either, I say either, but let's not call the whole thing off models for predicting the risk of lymph node involvement in patients with prostate cancer . Int J Radiat Oncol Biol Phys. 34:1996;749-751.
26. Roach M. III, Pickett B., Rosenthal S.A., Verhey L., Phillips T.L. Defining treatment margins for six field conformal irradiation of localized prostate cancer. Int J Radiat Oncol Biol Phys. 28:1994;267-275.
27. Consensus statement guidelines for PSA following radiation therapy . Int J Radiat Oncol Biol Phys. 37:1997;1035-1041.
28. Kaplan E.L., Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 53:1958;457-481.
29. Cox D.R. Regression models and life tables. J R Stat Soc. B34:1972;187-220.
30. Stock R.G., Stone N.N., Ianuzzi C., Unger P. Seminal vesicle biopsy and laparoscopic pelvic lymph node dissection implications for patient selection in the radiotherapeutic management of prostate cancer . Int J Radiat Oncol Biol Phys. 33:1995;815-821.
31. Stone N.N., Stock R.G., Unger P. Indications for seminal vesicle biopsy and laparoscopic pelvic lymph node dissection in men with localized carcinoma of the prostate. J Urol. 154:1995;1392-1396.
32. Freeman J.A., Esrig D., Grossfeld G.D., Stein J.P., Chen S.C., Young L.L., Taylor C.R., Skinner D.G., Lieskovsky G., Cote R.J. Incidence of occult lymph node metastases in pathological stage C (pT3N0) prostate cancer. J Urol. 154:1995;474-478.
33. Golimbu M., Morales P., Al-Askari S., Brown J. Extended pelvic lymphadenectomy for prostatic cancer. J Urol. 121:1979;617-620.
34. Overgaard M., Hansen P.S., Overgaard J., Rose C., Andersson M., Bach F., Kjaer M., Gadeberg C.C., Mouridsen H.T., Jensen M.-B., Zedeler K. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. N Engl J Med. 337:1997;949-955.
35. Ragaz J., Jackson S.M., Le N., Plenderleith I.H., Spinelli J.J., Basco V.E., Wilson K.S., Knowling M.A., Coppin M.L., Paradis M., Coldman A.J., Olivotto I.A. Adjuvant radiotherapy and cemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med. 337:1997;956-962.
36. Pinover W.H., Hanlon A., Lee W.R., Kaplan E.J., Hanks G.E. Prostate carcinoma patients upstaged by imaging and treated with irradiation. An outcome-based analysis. Cancer. 77:1996;1334-1341.
37. Pisansky T.M., Zincke H., Suman V.J., Bostwick D.G., Earle J.D., Oesterling J.E. Correlation of pretherapy prostate cancer characteristics with histologic findings from pelvic lymphadenectomy specimens. Int J Radiat Oncol Biol Phys. 34:1996;33-39.
38. Pisansky T.M., Kahn M.J., Rasp G.M., Cha S.S., Haddock M.G., Bostwick D.G. A multiple prognostic index predictive of disease outcome after irradiation for clinically localized prostate carcinoma. Cancer. 79:1997;337-344.